好色先生

好色先生

Explore the latest content from across our publications

Log In

Forgot Password?
Create New Account

Loading... please wait

Abstract Details

Patients Consenting to or Declining Extended Follow-up (Up to Ten Years) in the Carotid Revascularization Endarterectomy (CEA) versus Stenting (CAS) Trial (CREST)
Cerebrovascular Disease and Interventional Neurology
(-)
005
Authors/Disclosures
Alice J. Sheffet, PhD (CREST Administrative CenterRutgers, the State University of New Jersey)
PRESENTER
No disclosure on file
Ariane E. Mackey, MD (Hop De L'Enfant-Jesus Neuro) No disclosure on file
No disclosure on file
Wayne M. Clark, MD (Oregon Health Sciences Univ) Dr. Clark has nothing to disclose.
Michael D. Hill, MD (University of Calgary) Dr. Hill has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Boehringer Ingelheim. Dr. Hill has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sun Pharma. Dr. Hill has received stock or an ownership interest from Circle Neurovascular.
Jenifer Voeks Jenifer Voeks has nothing to disclose.
Susan E. Hughes (UMDNJ Department of Surgery) No disclosure on file
Meelee Tom (University of Medicine & Dentistry) No disclosure on file
No disclosure on file
Virginia J. Howard, PhD (University of Alabama At Birmingham) The institution of Dr. Howard has received research support from NIH. The institution of an immediate family member of Dr. Howard has received research support from NIH.
Thomas G. Brott, MD, FAAN (Mayo Clinic) Dr. Brott has nothing to disclose.